IndiaTickerANG Lifesciences India Ltd - 540694 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Company dossier
ANG Lifesciences
BSE:ANG · ISIN INE236W01016
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
ANG Lifesciences
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
ANG Lifesciences India Ltd - 540694 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended 31St March, 2026BSE · financial results · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Results - 31.03.2026BSE · financial results · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Considering The Standalone & Consolidated Audited Financial Results For The Quarter And Year Ended March 31, 2026BSE · financial results · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Clarification On Price Movement In SharesBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025BSE · financial results · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025BSE · financial results · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended And Nine Months Ended On 31St December, 2025.BSE · financial results · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Board Meeting Outcome For To Consider And Approve The Financial Results For The Quarter And Half Year Ended 30-09-2025BSE · financial results · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2025BSE · financial results · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended On 30Th September, 2025.BSE · financial results · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Appoitment Of Secretarial AuditorBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Clarification On Price MovementBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - 19Th Annual General Meeting (AGM) Of The Shareholders Of The Company Will Be Held On Tuesday, The 30Th September, 2025 At 11:30 AM Through Video Conference (VC) / Other Audio Visual Means (OAVM)BSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Intimation Of Book ClosureBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Notice Of 19Th AGM Of The Company Scheduled To Be Held On 30Th September 2025BSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Board Meeting Outcome For Intimation Of AGMBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30.06.2025.BSE · financial results · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Board Meeting Outcome For Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended June 30, 2025BSE · financial results · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Conducting Board Meeting To Consider And Approve Unaudited Standalone & Consolidated Financial Results For The First Quarter Ended 30Th June, 2025.BSE · financial results · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Outcome Of Board MeetingBSE · exchange filing · pdf
Source filing ANG Lifesciences India Ltd - 540694 - Financial Year Results For The Year Ended 31.03.2025BSE · financial results · pdf
Source filing